Billings Oncology Associates

Billings, Montana 59101

0 studies enrolling now · 5 studies all time

What they study most

Fallopian Tube Cancer, Kidney Cancer, Metastatic Cancer, Ovarian Cancer, Pancreatic Cancer, Primary Peritoneal Cavity Cancer, Prostate Cancer, Prostatic Neoplasms

Studies at this site

• ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment — Withdrawn before enrolling
• Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer — Completed
• BAY 59-8862 in Treating Patients With Advanced Kidney Cancer — Status unconfirmed
• Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer — Completed
• A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer — Completed